Data for Two Pandemics Covid and AMR.dta

This data is a STATA data set (.dta).
Based on 117 responses to a web survey in 29 European countries and interviews with bureaucrats in managerial positions, this paper investigates how people working professionally with antimicrobial resistance (AMR) assess the impact of the COVID-19 pandemic on their future long-run cooperation in the struggle against AMR, both within their own country and among the European countries. We measure whether the severity level of the AMR problem, cumulative COVID-19 death rates, and the daily number of confirmed new COVID-19 cases in their own countries have affected bureaucrats´ beliefs about long-run AMR collaboration. We find that around 40 percent of the bureaucrats believe that the cooperation will increase domestically and at the European level. However, there are considerable differences across regions: Eastern European bureaucrats are clearly the most pessimistic about future cooperation, while the Southern European and Nordic bureaucrats are the most optimistic. Neither the severity of the AMR problem nor the number of confirmed new COVID-19 cases in their own countries has a significant impact on bureaucrats´ beliefs about future collaboration.

本数据集为STATA（Stata）格式的.dta数据集。本研究基于29个欧洲国家的117份网络问卷调查回复，以及对管理岗位行政官员的访谈，针对专职从事抗菌药物耐药性（antimicrobial resistance，AMR）工作的人员，考察其如何评估新冠疫情（COVID-19 pandemic）对其本国及欧洲范围内抗菌药物耐药性防控工作中长期合作的影响。本研究同时检验了本国的抗菌药物耐药性问题严重程度、累计新冠死亡人数，以及每日新增确诊新冠病例数，是否会对行政官员关于抗菌药物耐药性防控长期合作的认知产生影响。研究发现，约40%的行政官员认为，本国及欧洲层面的抗菌药物耐药性防控合作将有所增强。但不同区域存在显著差异：东欧地区的行政官员对未来合作的态度最为悲观，而南欧与北欧地区的行政官员则最为乐观。本国抗菌药物耐药性问题的严重程度，以及每日新增确诊新冠病例数，均未对行政官员关于未来合作的认知产生显著影响。